Reducing Effect of Saikosaponin A, an Active Ingredient of Bupleurum falcatum, on Intake of Highly Palatable Food in a Rat Model of Overeating
Open Access
- 13 August 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 9, 369
Abstract
Recent lines of experimental evidence have indicated that saikosaponin A (SSA)—a bioactive ingredient of the medicinal plant, Bupleurum falcatum L.—potently and effectively reduced operant self-administration of chocolate and reinstatement of chocolate-seeking behavior in rats. The present study was designed to assess whether the protective properties of SSA on addictive-like, food-related behaviors generalize to a rat model of overeating of palatable food. To this end, rats were habituated to feed on a standard rat chow for 3 h/day; every 4 days, the 3-h chow-feeding session was followed by a 1-h availability of highly palatable, calorie-rich Danish butter cookies or Oreo chocolate cookies. Even though fed, rats consumed large amounts of cookies; intake of calories from cookies (consumed in 1 h) was even larger than that of calories from chow (consumed in 3 h). SSA (0, 0.25, 0.5, and 1 mg/kg, i.p.) was administered 10 min before cookie presentation. Treatment with SSA resulted in a dose-related decrease in intake of both butter and chocolate cookies. Administration of the cannabinoid CB1 receptor antagonist/inverse agonist, rimonabant (0, 0.3, 1, and 3 mg/kg, i.p.; tested as reference compound), produced a similar reduction in intake of butter cookies. These results (a) contribute to the set-up and validation of a rat model of overeating, characterized by the intake of large amounts of unnecessary calories and (b) provide an additional piece of evidence to the anorectic profile of SSA in rats.Keywords
This publication has 25 references indexed in Scilit:
- Reducing effect of an extract of Phaseolus vulgaris on food intake in mice — Focus on highly palatable foodsFitoterapia, 2013
- Inhibition of Opioid Transmission at the μ-Opioid Receptor Prevents Both Food Seeking and Binge-Like EatingNeuropsychopharmacology, 2012
- Motivation for palatable food despite consequences in an animal model of binge eatingInternational Journal of Eating Disorders, 2011
- Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of actionJournal of Pharmacy and Pharmacology, 2011
- Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in ratsBehavioural Pharmacology, 2008
- A high‐performance liquid chromatographic method for saikosaponin a quantification in rat plasmaBiomedical Chromatography, 2007
- Efficacy of Rimonabant and Other Cannabinoid CB1 Receptor Antagonists in Reducing Food Intake and Body Weight: Preclinical and Clinical DataCNS Drug Reviews, 2006
- The potential use of selective 5-HT2Cagonists in treating obesityExpert Opinion on Investigational Drugs, 2006
- Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in ratsBrain Research, 2004